|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen AY, Jemal A and Ward EM: Increasing
incidence of differentiated thyroid cancer in the United States,
1988–2005. Cancer. 115:3801–3807. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jung CK, Little MP, Lubin JH, Brenner AV,
Wells SA Jr, Sigurdson AJ and Nikiforov YE: The increase in thyroid
cancer incidence during the last four decades is accompanied by a
high frequency of BRAF mutations and a sharp increase in RAS
mutations. J Clin Endocrinol Metab. 99:E276–E285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sipos JA and Mazzaferri EL: Thyroid cancer
epidemiology and prognostic variables. Clin Oncol (R Coll Radiol).
22:395–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kondo T, Ezzat S and Asa SL: Pathogenetic
mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer.
6:292–306. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luster M, Weber T and Verburg FA:
Differentiated thyroid cancer-personalized therapies to prevent
overtreatment. Nat Rev Endocrinol. 10:563–574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vasko V, Espinosa AV, Scouten W, He H,
Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la
Chapelle A, et al: Gene expression and functional evidence of
epithelial-to-mesenchymal transition in papillary thyroid carcinoma
invasion. Proc Natl Acad Sci USA. 104:pp. 2803–2808. 2007;
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zavadil J and Böttinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shook D and Keller R: Mechanisms,
mechanics and function of epithelial-mesenchymal transitions in
early development. Mech Dev. 120:1351–1383. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lv N, Shan Z, Gao Y, Guan H, Fan C, Wang H
and Teng W: Twist1 regulates the epithelial-mesenchymal transition
via the NF-kappaB pathway in papillary thyroid carcinoma.
Endocrine. 51:469–477. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Buehler D, Hardin H, Shan W,
Montemayor-Garcia C, Rush PS, Asioli S, Chen H and Lloyd RV:
Expression of epithelial-mesenchymal transition regulators SNAI2
and TWIST1 in thyroid carcinomas. Mod Pathol. 26:54–61. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leitinger B and Kwan AP: The discoidin
domain receptor DDR2 is a receptor for type X collagen. Matrix
Biol. 25:355–364. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Carafoli F, Bihan D, Stathopoulos S,
Konitsiotis AD, Kvansakul M, Farndale RW, Leitinger B and
Hohenester E: Crystallographic insight into collagen recognition by
discoidin domain receptor 2. Structure. 17:1573–1581. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang K, Corsa CA, Ponik SM, Prior JL,
Piwnica-Worms D, Eliceiri KW, Keely PJ and Longmore GD: The
collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to
facilitate breast cancer metastasis. Nat Cell Biol. 15:677–687.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim D, Ko P, You E and Rhee S: The
intracellular juxtamembrane domain of discoidin domain receptor 2
(DDR2) is essential for receptor activation and DDR2-mediated
cancer progression. Int J Cancer. 135:2547–2557. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu H, Bihan D, Chang F, Huang PH, Farndale
RW and Leitinger B: Discoidin domain receptors promote α1β1-and
α2β1-integrin mediated cell adhesion to collagen by enhancing
integrin activation. PLoS One. 7:e522092012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie B, Lin W, Ye J, Wang X, Zhang B, Xiong
S, Li H and Tan G: DDR2 facilitates hepatocellular carcinoma
invasion and metastasis via activating ERK signaling and
stabilizing SNAIL1. J Exp Clin Cancer Res. 34:1012015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu J, Lu W, Zhang S, Zhu C, Ren T, Zhu T,
Zhao H, Liu Y and Su J: Overexpression of DDR2 contributes to cell
invasion and migration in head and neck squamous cell carcinoma.
Cancer Biol Ther. 15:612–622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang YG, Xu L, Jia RR, Wu Q, Wang T, Wei
J, Ma JL, Shi M and Li ZS: DDR2 induces gastric cancer cell
activities via activating mTORC2 signaling and is associated with
clinicopathological characteristics of gastric cancer. Dig Dis Sci.
61:2272–2283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rodrigues R, Roque L, Espadinha C, Pinto
A, Domingues R, Dinis J, Catarino A, Pereira T and Leite V:
Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array
analysis in aneuploid papillary thyroid carcinomas. Oncol Rep.
18:917–926. 2007.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Walsh LA, Nawshad A and Medici D:
Discoidin domain receptor 2 is a critical regulator of
epithelial-mesenchymal transition. Matrix Biol. 30:243–247. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Provenzano PP, Inman DR, Eliceiri KW and
Keely PJ: Matrix density-induced mechanoregulation of breast cell
phenotype, signaling and gene expression through a FAK-ERK linkage.
Oncogene. 28:4326–4343. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang ZL, Fan ZQ, Jiang HD and Qu JM:
Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal
transition in human lung cancer cells via activating MEK-ERK
signaling. Carcinogenesis. 34:638–646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Olaso E, Ikeda K, Eng FJ, Xu L, Wang LH,
Lin HC and Friedman SL: DDR2 receptor promotes MMP-2-mediated
proliferation and invasion by hepatic stellate cells. J Clin
Invest. 108:1369–1378. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Labrador JP, Azcoitia V, Tuckermann J, Lin
C, Olaso E, Mañes S, Brückner K, Goergen JL, Lemke G, Yancopoulos
G, et al: The collagen receptor DDR2 regulates proliferation and
its elimination leads to dwarfism. EMBO Rep. 2:446–452. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Strippoli R, Benedicto I, Pérez Lozano ML,
Cerezo A, López-Cabrera M and del Pozo MA:
Epithelial-to-mesenchymal transition of peritoneal mesothelial
cells is regulated by an ERK/NF-kappaB/Snail1 pathway. Dis Model
Mech. 1:264–274. 2008. View Article : Google Scholar : PubMed/NCBI
|
